192 related articles for article (PubMed ID: 9829755)
21. Dietary flaxseed interaction with tamoxifen induced tumor regression in athymic mice with MCF-7 xenografts by downregulating the expression of estrogen related gene products and signal transduction pathways.
Chen J; Power KA; Mann J; Cheng A; Thompson LU
Nutr Cancer; 2007; 58(2):162-70. PubMed ID: 17640162
[TBL] [Abstract][Full Text] [Related]
22. Targeting of nuclear factor kappaB Pathways by dehydroxymethylepoxyquinomicin, a novel inhibitor of breast carcinomas: antitumor and antiangiogenic potential in vivo.
Matsumoto G; Namekawa J; Muta M; Nakamura T; Bando H; Tohyama K; Toi M; Umezawa K
Clin Cancer Res; 2005 Feb; 11(3):1287-93. PubMed ID: 15709200
[TBL] [Abstract][Full Text] [Related]
23. [Antitumor activity of a new antiestrogenic drug, toremifene (NK622) against human breast cancer xenografts in nude mice].
Kuroiwa S; Koyama M; Watanabe N; Ekimoto H; Ohnishi Y; Saito M; Maruo K; Inaba M; Tashiro T; Yamori T
Gan To Kagaku Ryoho; 1993 Apr; 20(5):617-23. PubMed ID: 8470919
[TBL] [Abstract][Full Text] [Related]
24. Growth-inhibitory effects of CD40 ligand (CD154) and its endogenous expression in human breast cancer.
Tong AW; Papayoti MH; Netto G; Armstrong DT; Ordonez G; Lawson JM; Stone MJ
Clin Cancer Res; 2001 Mar; 7(3):691-703. PubMed ID: 11297266
[TBL] [Abstract][Full Text] [Related]
25. 17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells.
Zheng J; Kulp SK; Zhang Y; Sugimoto Y; Dayton MA; Govindan MV; Brueggemeier RW; Lin YC
Anticancer Res; 2000; 20(1A):11-9. PubMed ID: 10769629
[TBL] [Abstract][Full Text] [Related]
26. Anti-prostate cancer and anti-breast cancer activities of two peptides derived from alpha-fetoprotein.
Caceres G; Dauphinee MJ; Eisele LE; MacColl R; Mizejewski GJ
Anticancer Res; 2002; 22(5):2817-20. PubMed ID: 12530002
[TBL] [Abstract][Full Text] [Related]
27. Effects of a new clinically relevant antiestrogen (GW5638) related to tamoxifen on breast and endometrial cancer growth in vivo.
Dardes RC; O'Regan RM; Gajdos C; Robinson SP; Bentrem D; De Los Reyes A; Jordan VC
Clin Cancer Res; 2002 Jun; 8(6):1995-2001. PubMed ID: 12060645
[TBL] [Abstract][Full Text] [Related]
28. Effects of the antiestrogen tamoxifen and the aromatase inhibitor letrozole on serum hormones and bone characteristics in a preclinical tumor model for breast cancer.
Núñez NP; Jelovac D; Macedo L; Berrigan D; Perkins SN; Hursting SD; Barrett JC; Brodie A
Clin Cancer Res; 2004 Aug; 10(16):5375-80. PubMed ID: 15328175
[TBL] [Abstract][Full Text] [Related]
29. Genistein stimulates growth of human breast cancer cells in a novel, postmenopausal animal model, with low plasma estradiol concentrations.
Ju YH; Allred KF; Allred CD; Helferich WG
Carcinogenesis; 2006 Jun; 27(6):1292-9. PubMed ID: 16537557
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of tumor growth and metastasis with antisense oligonucleotides (Cantide) targeting hTERT in an in situ human hepatocellular carcinoma model.
Lin RX; Tuo CW; Lü QJ; Zhang W; Wang SQ
Acta Pharmacol Sin; 2005 Jun; 26(6):762-8. PubMed ID: 15916744
[TBL] [Abstract][Full Text] [Related]
31. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.
Li Y; Yu DC; Chen Y; Amin P; Zhang H; Nguyen N; Henderson DR
Cancer Res; 2001 Sep; 61(17):6428-36. PubMed ID: 11522637
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of AP-1 transcription factor causes blockade of multiple signal transduction pathways and inhibits breast cancer growth.
Liu Y; Ludes-Meyers J; Zhang Y; Munoz-Medellin D; Kim HT; Lu C; Ge G; Schiff R; Hilsenbeck SG; Osborne CK; Brown PH
Oncogene; 2002 Oct; 21(50):7680-9. PubMed ID: 12400010
[TBL] [Abstract][Full Text] [Related]
33. Similarity between natural and recombinant human alpha-fetoprotein as inhibitors of estrogen-dependent breast cancer growth.
Bennett JA; Semeniuk DJ; Jacobson HI; Murgita RA
Breast Cancer Res Treat; 1997 Sep; 45(2):169-79. PubMed ID: 9342442
[TBL] [Abstract][Full Text] [Related]
34. Elevated serum alpha fetoprotein levels in postmenopausal women with primary breast carcinoma.
Sarcione EJ; Biddle W
Dis Markers; 1987 Jun; 5(2):75-9. PubMed ID: 2458881
[TBL] [Abstract][Full Text] [Related]
35. Growth inhibition of estrogen-sensitive rat mammary tumors. Effect of an alpha-fetoprotein-secreting hepatoma.
Sonnenschein C; Ucci AA; Soto AM
J Natl Cancer Inst; 1980 May; 64(5):1147-52. PubMed ID: 6154169
[TBL] [Abstract][Full Text] [Related]
36. Hormones of pregnancy, alpha-feto protein, and reduction of breast cancer risk.
Jacobson HI; Lemanski N; Narendran A; Agarwal A; Bennett JA; Andersen TT
Adv Exp Med Biol; 2008; 617():477-84. PubMed ID: 18497072
[TBL] [Abstract][Full Text] [Related]
37. Differential effects of butyrate derivatives on human breast cancer cells grown as organotypic nodules in vitro and as xenografts in vivo.
Planchon P; Magnien V; Beaupain R; Mainguene C; Ronco G; Villa P; Brouty-Boye D
In Vivo; 1992; 6(6):605-10. PubMed ID: 1296809
[TBL] [Abstract][Full Text] [Related]
38. The influence of antisera specific for alpha-fetoprotein and mouse serum albumin on the viability and protein synthesis of cultured mouse hepatoma cells.
Allen RP; Ledford BE
Cancer Res; 1977 Mar; 37(3):696-701. PubMed ID: 65216
[TBL] [Abstract][Full Text] [Related]
39. Scintigraphic detection of breast cancer xenografts with Tc-99m natural and recombinant human alpha-fetoprotein.
Line BR; Feustel PJ; Festin SM; Andersen TT; Dansereau RN; Lukasiewicz RL; Zhu S; Bennett JA
Cancer Biother Radiopharm; 1999 Dec; 14(6):485-94. PubMed ID: 10850335
[TBL] [Abstract][Full Text] [Related]
40. Effect of anti-alpha-fetoprotein serum on growth and plating efficiency of alpha-fetoprotein-producing hepatoma cells in vitro.
Nishina K; Tsutamune T; Tokiwa T; Miyazaki M; Sato J
Acta Med Okayama; 1975 Aug; 29(4):319-26. PubMed ID: 55059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
